Insuficencia cardíaca. Nuevos conceptos, nuevos medicamentos / Heart failure. New concepts, new medications
Rev. méd. Panamá
;
19(1): 1-7, Jan. 1994.
Artigo
em Espanhol
| LILACS
| ID: lil-409995
RESUMO
It is possible, in our midst, to obtain a survival rate of 68% and a marked improvement in the functional capacity of patients with advanced cardiac insufficiency due to systolic myocardial dysfunction through the combined use of ACE inhibitors, diuretics and digitalis as the main therapeutic agents. Patients with cardiac failure due to atherosclerotic heart disease have a slight better prognosis than those whose failure is secondary to dilated idiopathic congestive cardiomyopathy. The incidence of arrhythmias, sudden death and peripheral embolism suggest that the use of Amiodarone as antiarrhythmic agent and of Warfarin as anticoagulant should be increased. Each of these agents was used in only 26% of our patients
Buscar no Google
Índice:
LILACS (Américas)
Assunto principal:
Insuficiência Cardíaca
Tipo de estudo:
Estudo diagnóstico
/
Estudo observacional
/
Estudo prognóstico
/
Fatores de risco
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. méd. Panamá
Assunto da revista:
Medicina
Ano de publicação:
1994
Tipo de documento:
Artigo
País de afiliação:
Panamá
Instituição/País de afiliação:
Universidad de Panamá/PA
Similares
MEDLINE
...
LILACS
LIS